Lisata Therapeutics LSTA
Form ARS filed
Annual report to shareholders
- Form
- ARS
- Filed
- Importance
- Routine
- Accession
- 0001140361-26-040000
- Form ARS filed
- Date: Oct 19, 2026
- Company: Lisata Therapeutics
Written from the ARS on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Nanoviricides NNVC public float $24M, Dec 31, 2025
- Tenax Therapeutics TENX public float $24M, Jun 30, 2025
- Aytu Biopharma AYTU public float $24M, Dec 31, 2025
- Dyadic International DYAI public float $24M, Jun 30, 2025
- Kala Bio KALA public float $25M, Jun 30, 2025
